Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemia

Despite several new therapeutic options for acute myeloid leukemia (AML), disease relapse remains a significant challenge. We have previously demonstrated that augmenting ceramides can counter various drug‐resistance mechanisms, leading to enhanced cell death in cancer cells and extended survival in...

Descripción completa

Detalles Bibliográficos
Autores principales: Khokhlatchev, Andrei V., Sharma, Arati, Deering, Tye G., Shaw, Jeremy J. P., Costa‐Pinheiro, Pedro, Golla, Upendarrao, Annageldiyev, Charyguly, Cabot, Myles C., Conaway, Mark R., Tan, Su‐Fern, Ung, Johnson, Feith, David J., Loughran, Thomas P., Claxton, David F., Fox, Todd E., Kester, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544744/
https://www.ncbi.nlm.nih.gov/pubmed/36106439
http://dx.doi.org/10.1096/fj.202200765R

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544744/
https://www.ncbi.nlm.nih.gov/pubmed/36106439
http://dx.doi.org/10.1096/fj.202200765R

Ejemplares similares